Precision Neuroscience
Precision Neuroscience Raises $102M Series C | Brain-Computer Interface
Precision Neuroscience Closes $102M for BCI Development
Precision Neuroscience, developing minimally invasive brain-computer interface technology, has raised $102 million in Series C funding.
The round was led by B Capital with participation from Steadview Capital and Alumni Ventures.
Key Highlights
- Total funding to date: $155 million
- Minimally invasive neural implant approach
- Founded by Neuralink co-founder
Company Overview
Precision Neuroscience is developing minimally invasive brain-computer interface technology to restore function for patients with neurological conditions, competing with Neuralink in the emerging BCI market.
Company Info
Investors (3)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free